全球運動醫學市場 - 2023-2030 年
市場調查報告書
商品編碼
1316301

全球運動醫學市場 - 2023-2030 年

Global Sports Medicine Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年,全球運動醫學市場規模達到70 億美元,預計到2030 年將實現利潤豐厚的成長,達到113 億美元。在預測期內(2023-2030 年),全球運動醫學市場的複合年成長率預計將達到6.3%。

運動損傷數量的增加、產品發布的增加、新療法的推出、再生醫學的進步以及對微創手術需求的增加等因素有望在預測期內推動全球運動醫學市場的成長。

市場動態

市場發展推動運動醫學市場成長

據估計,不斷成長的市場發展將在預測期內推動全球運動醫學市場的成長。例如,2023 年3 月,醫療技術公司Smith+Nephew 推出了UltraTRAC QUAD ACL 重建技術,包括新型QUADTRAC 股四頭肌肌腱採集引導系統、X-WING 移植物準備系統和ULTRABUTTON 可調固定裝置系列。

同樣,在2022 年7 月於科羅拉多斯普林斯舉行的2022 年美國運動醫學矯形外科學會(AOSSM)年會上,全球醫療技術公司Smith+Nephew 也推出了強大的陣容,其中包括幾項精良的關節修復解決方案和一系列廣泛的教育活動。

不斷進步的技術有望為全球運動醫學市場帶來成長機會

與日俱增的進步為全球運動醫學市場帶來了利潤豐厚的成長機會。例如,2023 年6 月,Aspetar、骨科和運動醫學醫院推出了衝擊波療法,使其站在了運動醫學的最前沿。

利用這一尖端技術,這種最先進的治療方式正在改變組織的恢復和運動相關損傷的疼痛減輕,對運動員和個人產生了深遠的影響。

嚴格監管機構的存在預計將在預測期內阻礙全球運動醫學市場的發展

新開發的運動醫學藥物在審批方面存在嚴格的監管機構,這阻礙了預測期內全球市場的成長。例如,監督運動醫學授權和商業化的主要監管機構包括美國食品藥品管理局(USFDA)和歐洲藥品管理局(歐盟負責評估和監督歐盟藥品的機構)。

COVID-19 影響分析

COVID-19 在全球許多國家的流行和封鎖影響了各行業公司的財務健康。因此,在COVID-19 公共衛生緊急狀態期間,美國食品和藥物管理局(FDA) 發布了指導方針,其中包括幫助申辦者和研究人員的一般注意事項,以確保試驗參與者的安全,遵守良好臨床實踐(GCP),並將試驗完整性的風險降至最低。

俄烏戰爭影響分析

俄烏衝突被認為對全球運動醫學市場的影響不大,因為該地區運動損傷的發生率較低,而且缺乏主要的市場參與者。烏克蘭診所雖然繼續忍受俄羅斯軍隊的入侵,但迫於死亡人數不斷增加和醫療援助有限的壓力。所有藥品都出現短缺。同樣,基礎材料進出口的重要性預計將在預測期內對全球運動醫學市場的成長產生輕微影響。

目 錄

第1 章:研究方法與範圍

  • 研究方法
  • 報告的研究目標和範圍

第2章:定義和概述

第3章:執行摘要

  • 按產品分類
  • 按應用分類
  • 按最終用戶分類
  • 按地區分類

第四章:動態

  • 影響因素
    • 驅動因素
      • 市場日益發展
      • 運動傷害事件日益增多
    • 制約因素
      • 嚴格的監管機構
    • 機會
      • 不斷進步
    • 影響分析

第5 章:行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第6 章:COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情況
    • COVID-19 期間的情景
    • COVID-19 後的情況
  • COVID-19 期間的定價動態
  • 供需關係
  • 大流行期間與市場相關的政府計劃
  • 製造商的戰略計劃
  • 結論

第7 章:按產品分類

  • 車身重建與修復
  • 身體支持和恢復
  • 身體監測和評估設備
  • 附件

第8 章:按應用分類

  • 踝關節和足部損傷
  • 背部和脊椎損傷
  • 肘部和腕部損傷
  • 髖關節損傷
  • 其他

第9章:按最終用戶分類

  • 醫院
  • 專科診所
  • 其他

第10 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第11 章:競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併與收購分析

第十二章:公司簡介

  • Arthrex Inc.
    • 公司概況
    • 產品組合和說明
    • 財務概況
    • 主要發展
  • CONMED Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Mueller Sports Medicine Inc.
  • Performance Health
  • Smith & Nephew
  • Stryker Corporation
  • Wright Medical Group
  • Zimmer Biomet Holdings Inc.

第13 章:附錄

簡介目錄
Product Code: MD843

Market Overview

The global sports medicine market reached US$ 7.0 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 11.3 billion by 2030. The global sports medicine market is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).

The increase in the number of sports injuries, rising product launches, introductions of new therapies, advancements in regenerative medicine, and increasing requirements for minimally invasive surgery are among the factors expected to boost the global sports medicine market growth in the forecast period.

Market Dynamics

Increasing Market Developments Drive The Growth of the Sports Medicine Market

The increasing market developments are estimated to boost the global sports medicine market growth in the forecast period. For instnace, in March 2023, Smith+Nephew, medical technology corporation, launched the UltraTRAC QUAD ACL Reconstruction Technique comprising of the new QUADTRAC Quadriceps Tendon Harvest Guide System, X-WING Graft Preparation System and family of ULTRABUTTON Adjustable Fixation Devices.

Likewise, in July 2022, Smith+Nephew, the global medical technology corpoLikewisentroduced a potent line-up featuring a few of its refined joint repair solutions and a wide collection of educational actions in the 2022 American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting being held in Colorado Springs.

The Increase Advancements are Expected to Present the Global Sports Medicine Market With Growth Opportunities

The increasing advancements are presenting the global sports medicine market with lucrative growth opportunities. For instnace, in June 2023, Aspetar, Orthopaedic, and Sports Medicine Hospital introduced its Shockwave Therapy putting it at the forefront of sports medicine.

Employing this cutting-edge technology, this state-of-the-art therapy modality is altering tissue restoration and pain drop-in sports-associated injuries, making an influential impact on athletes and individuals.

The Presence of Stringent Regulatory Bodies is Estimated to Hamper the Global Sports Medicine Market During The Forecast Period

The presence of stringent regulatory bodies for the approval of newly developed drugs for sports medicine is hampering the global market growth in the forecast period. For instnace, the major regulatory bodies supervising the authorization and commercialization of sports medicine include the United States Food and Drug Administration (USFDA) and the European Medicines Agency, an agency of the European Union in charge of the evaluation and supervision of pharmaceutical products in the European Union.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is thought to hold a moderate influence on the global sports medicine market, as there is a low incidence of sports injuries and a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all Products of medications. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global sports medicine market growth in the forecast period.

Segment Analysis

The global sports medicine market is segmented based on product, application, end-user, and region.

The Ankle & Foot Injuries Application is Estimated to Dominate the Global Sports Medicine Market

Owing to the increasing product introduction for the foot and ankle sports-injury applications segment into the global sports medicine market, the segment is estimated to hold a large share of the global market accounting for about 43.9%. For instance, in June 2022, Mueller Sports Medicine, an industry leader in sports medicine for the last six decades, launched its SKY Ankle Stabilizer.

As ankle sprains are the No.1 sports injury, SKY Stabilizer strives to deliver fit ankles and avert chronic ankle instability. It was developed for participants interested in vertical jumping sports such as basketball and volleyball as Mueller concentrated on simple elements of inversion sprains and biomechanics.

Geographical Analysis

Europe is Estimated to Hold 27.6% of the Market Share Owing to the Growing Cases of Chronic Conditions in this Region

Owing to the increasing incidences of sports injury in this region the European sports medicine market is estimated to hold around 27.6% of the global market share by 2030. For instance, in September 2022, London - Howden, the international insurance vendor, reported its European Football Injury Index for the 2021/2022 season for the guys' tournament, which demonstrates that injury expenses for the mainland's leading leagues broke via the half-a-billion-pound spot for the very foremost term (£513.23m/€610.75m). The whole number of injuries sustained throughout Europe's top five clubs was around 4,810 over the course of the previous season denoting a 20% boost in the 2020/2021 season.

Competitive Landscape

The major global players in the sports medicine market include: Arthrex Inc., CONMED Corporation, Johnson & Johnson, Medtronic PLC, Mueller Sports Medicine Inc., Performance Health, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Biomet Holdings Inc. among others.

Why Purchase the Report?

  • To visualize the global sports medicine market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of sports medicine market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available in Excel consisting of key products of all the major players.

The global sports medicine market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Market Developments
      • 4.1.1.2. Growing Incidences of Sports Injuries
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Authorities
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Body Reconstruction and Repair *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Body Support and Recovery
  • 7.4. Body Monitoring and Evaluation Devices
  • 7.5. Accessories

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Ankle & Foot Injuries*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Back & Spine Injuries
  • 8.4. Elbow & Wrist Injuries
  • 8.5. Hip Injuries
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Other

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Arthrex Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. CONMED Corporation
  • 12.3. Johnson & Johnson
  • 12.4. Medtronic PLC
  • 12.5. Mueller Sports Medicine Inc.
  • 12.6. Performance Health
  • 12.7. Smith & Nephew
  • 12.8. Stryker Corporation
  • 12.9. Wright Medical Group
  • 12.10. Zimmer Biomet Holdings Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us